The research is based on shipment records of key ingredients from 2024 and 2025, and uses the same methodology that has been used in the past to accurately predict the prices of generic medicines for HIV, hepatitis C and some cancer drugs.
Ok, but that's over a multi-decade timeframe, not something that could happen right now.